$2500 | Single User
$5000 | Site License
$7500 | Global License

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

Published by Global Data: 31 Dec 2018 | 230671 | In Stock

Introduction

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018" provides an overview of Central Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Five Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 18

    Clinical Trials in G7 Countries by Trial Status 19

    Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 21

    Clinical Trials by Phase in E7 Countries 23

    Clinical Trials in E7 Countries by Trial Status 24

    Clinical Trials by Phase 25

    In Progress Trials by Phase 26

    Clinical Trials by Trial Status 27

    Clinical Trials by End Point Status 29

    Subjects Recruited Over a Period of Time 30

    Clinical Trials by Sponsor Type 31

    Prominent Sponsors 32

    Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials 34

    Prominent Drugs 36

    Clinical Trial Profile Snapshots 37

    Appendix 103

    Abbreviations 103

    Definitions 103

    Research Methodology 104

    Secondary Research 104

    About GlobalData 104

    Contact Us 105

    Source 105

List Of Tables
in Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Tables

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2018* 7

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17

Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 22

Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2018* 25

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List Of Figures, Charts and Diagrams
in Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Figures

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15

Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16

Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18

Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19

Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21

Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26

Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34

Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

GlobalData Methodology 104

Additional Details

Publisher

Global Data

Publisher Information

Reference

230671 | GDHC5535CTIDB

Number of Pages

105

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Central Nervous System Partnering 2010-2016: Deal trends, players and financials
Global Central Nervous System Partnering 2010 to 2016 provides the full collection of Central Nervou...
01 Nov 2016 by Current Partnering USD $3,495 More Info
Global Central Nervous System Partnering 2010-2016: Deal trends, players and financials
Global Central Nervous System Partnering 2010 to 2016 provides the full collection of Central Nervou...
01 Oct 2016 by Current Partnering USD $3,495 More Info
Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
SummaryThe delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neur...
01 Oct 2016 by Jain PharmaBiotech USD $3,000 More Info
MediPoint: Central Vascular Access Devices - Global Analysis and Market Forecasts
MediPoint: Central Vascular Access Devices - Global Analysis and Market ForecastsSummaryCentral vasc...
01 Aug 2016 by Global Data USD $5,995 More Info
Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016
Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016SummaryGlob...
01 Jun 2016 by Global Data USD $2,500 More Info
Central Venous Catheters - Medical Devices Pipeline Assessment, 2016
Central Venous Catheters - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devi...
01 Jun 2016 by Global Data USD $2,500 More Info
Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016
Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016SummaryGlob...
01 Jun 2016 by Global Data USD $2,500 More Info
Central Venous Catheters - Medical Devices Pipeline Assessment, 2016
Central Venous Catheters - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devi...
01 Jun 2016 by Global Data USD $2,500 More Info
Global Central Nervous System (CNS) Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
A biomarker is biological feature that can be used to measure the presence or progress of disease or...
03 Mar 2016 by Occams Business Research USD $3,900 More Info
Central Venous Catheters - Medical Devices Pipeline Assessment, 2015
Central Venous Catheters - Medical Devices Pipeline Assessment, 2015SummaryGlobalData's Medical Devi...
09 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data